Inappropriate schedule of vaccine administered; had a sore throat.; tested positive for Covid-19; felt super tired instead of super sick/ feels tired; mild headache.; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (had a sore throat.), SARS-COV-2 TEST POSITIVE (tested positive for Covid-19), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered), FATIGUE (felt super tired instead of super sick/ feels tired) and HEADACHE (mild headache.) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 069F21A, 025C21A and 019B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Dec-2021, the patient experienced FATIGUE (felt super tired instead of super sick/ feels tired) and HEADACHE (mild headache.). On 11-Jan-2022, the patient experienced OROPHARYNGEAL PAIN (had a sore throat.) and SARS-COV-2 TEST POSITIVE (tested positive for Covid-19). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). At the time of the report, OROPHARYNGEAL PAIN (had a sore throat.) had resolved and SARS-COV-2 TEST POSITIVE (tested positive for Covid-19), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered), FATIGUE (felt super tired instead of super sick/ feels tired) and HEADACHE (mild headache.) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Jan-2022, SARS-CoV-2 test: positive (Positive) Patient tested positive for COVID 19.         No concomitant medications were reported.  Treatment information was not provided. The patient received her Moderna COVID 19 booster dose on 03 December 2021. The patient received her booster dose in the left arm shoulder deltoid muscle. The patient experienced similar reactions to the first two doses of Moderna COVID 19 vaccine but her symptoms were lighter. Patient felt super tired instead of super sick. Patient had a mild headache. The patient tested positive for COVID 19 on 11 January 2022. Patient feels tired and had a sore throat. The sore throat was gone.  This is a case of Inappropriate Schedule of Vaccination that concerns a 27-year-old female patient with no medical history, who experienced the unexpected non-serious adverse event of special interest SARS-CoV-2 Test Positive. The event occurred 9 days after receiving the third dose of mRNA-1273 Vaccine, following vaccination, the patient also experienced other non-serious adverse events such as Fatigue, Headache, and Oropharyngeal pain. The rechallenge is not unknown for event Headache as it occurred on the second dose however outcome was unknown. SARS-CoV-2 test yielded positive results, no other clinical or treatment details were given. It was reported that the outcome of the event has resolved. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.   This case was linked to MOD-2022-454745, MOD-2022-454755 (Patient Link).; Sender's Comments: This is a case of Inappropriate Schedule of Vaccination that concerns a 27-year-old female patient with no medical history, who experienced the unexpected non-serious adverse event of special interest SARS-CoV-2 Test Positive. The event occurred 9 days after receiving the third dose of mRNA-1273 Vaccine, following vaccination, the patient also experienced other non-serious adverse events such as Fatigue, Headache, and Oropharyngeal pain. The rechallenge is not unknown for event Headache as it occurred on the second dose however outcome was unknown. SARS-CoV-2 test yielded positive results, no other clinical or treatment details were given. It was reported that the outcome of the event has resolved. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.